nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergotamine—migraine—Prednisone—rheumatoid arthritis	0.697	1	CpDpCtD
Ergotamine—CYP1A2—Leflunomide—rheumatoid arthritis	0.0276	0.139	CbGbCtD
Ergotamine—ABCB1—Methylprednisolone—rheumatoid arthritis	0.0197	0.099	CbGbCtD
Ergotamine—CYP3A4—Ergocalciferol—rheumatoid arthritis	0.016	0.0804	CbGbCtD
Ergotamine—ABCB1—Betamethasone—rheumatoid arthritis	0.0128	0.0643	CbGbCtD
Ergotamine—ABCB1—Prednisolone—rheumatoid arthritis	0.0126	0.0635	CbGbCtD
Ergotamine—ABCB1—Hydrocortisone—rheumatoid arthritis	0.012	0.0602	CbGbCtD
Ergotamine—ABCB1—Prednisone—rheumatoid arthritis	0.0119	0.06	CbGbCtD
Ergotamine—CYP3A4—Methylprednisolone—rheumatoid arthritis	0.0118	0.0593	CbGbCtD
Ergotamine—ABCB1—Cyclosporine—rheumatoid arthritis	0.0113	0.0568	CbGbCtD
Ergotamine—CYP3A4—Triamcinolone—rheumatoid arthritis	0.00894	0.0449	CbGbCtD
Ergotamine—CYP3A4—Betamethasone—rheumatoid arthritis	0.00767	0.0386	CbGbCtD
Ergotamine—CYP3A4—Prednisolone—rheumatoid arthritis	0.00757	0.038	CbGbCtD
Ergotamine—ABCB1—Dexamethasone—rheumatoid arthritis	0.00745	0.0374	CbGbCtD
Ergotamine—CYP3A4—Hydrocortisone—rheumatoid arthritis	0.00717	0.0361	CbGbCtD
Ergotamine—CYP3A4—Prednisone—rheumatoid arthritis	0.00715	0.0359	CbGbCtD
Ergotamine—CYP3A4—Cyclosporine—rheumatoid arthritis	0.00678	0.0341	CbGbCtD
Ergotamine—ABCB1—Methotrexate—rheumatoid arthritis	0.00598	0.0301	CbGbCtD
Ergotamine—CYP3A4—Dexamethasone—rheumatoid arthritis	0.00446	0.0224	CbGbCtD
Ergotamine—Paresthesia of limbs—Methotrexate—rheumatoid arthritis	0.00107	0.0672	CcSEcCtD
Ergotamine—Hypertension—Ergocalciferol—rheumatoid arthritis	0.000491	0.0308	CcSEcCtD
Ergotamine—Pain—Ergocalciferol—rheumatoid arthritis	0.000397	0.0249	CcSEcCtD
Ergotamine—Asthenia—Ergocalciferol—rheumatoid arthritis	0.000333	0.0209	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Penicillamine—rheumatoid arthritis	0.000318	0.02	CcSEcCtD
Ergotamine—Cyanosis—Methotrexate—rheumatoid arthritis	0.00029	0.0182	CcSEcCtD
Ergotamine—Nausea—Ergocalciferol—rheumatoid arthritis	0.000276	0.0173	CcSEcCtD
Ergotamine—Pruritus—Auranofin—rheumatoid arthritis	0.000268	0.0168	CcSEcCtD
Ergotamine—Vomiting—Auranofin—rheumatoid arthritis	0.000241	0.0151	CcSEcCtD
Ergotamine—Nausea—Auranofin—rheumatoid arthritis	0.000225	0.0141	CcSEcCtD
Ergotamine—Vomiting—Penicillamine—rheumatoid arthritis	0.000222	0.0139	CcSEcCtD
Ergotamine—Nausea—Penicillamine—rheumatoid arthritis	0.000208	0.013	CcSEcCtD
Ergotamine—Myalgia—Azathioprine—rheumatoid arthritis	0.00019	0.0119	CcSEcCtD
Ergotamine—Vertigo—Leflunomide—rheumatoid arthritis	0.000189	0.0119	CcSEcCtD
Ergotamine—Hypoaesthesia—Cyclosporine—rheumatoid arthritis	0.000186	0.0116	CcSEcCtD
Ergotamine—Hypertension—Leflunomide—rheumatoid arthritis	0.000182	0.0114	CcSEcCtD
Ergotamine—Myalgia—Leflunomide—rheumatoid arthritis	0.000179	0.0112	CcSEcCtD
Ergotamine—Bradycardia—Prednisolone—rheumatoid arthritis	0.000173	0.0108	CcSEcCtD
Ergotamine—Bradycardia—Hydrocortisone—rheumatoid arthritis	0.000169	0.0106	CcSEcCtD
Ergotamine—Tachycardia—Leflunomide—rheumatoid arthritis	0.000168	0.0105	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Azathioprine—rheumatoid arthritis	0.000166	0.0104	CcSEcCtD
Ergotamine—Bradycardia—Triamcinolone—rheumatoid arthritis	0.000159	0.00997	CcSEcCtD
Ergotamine—Bradycardia—Methylprednisolone—rheumatoid arthritis	0.000159	0.00995	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Leflunomide—rheumatoid arthritis	0.000157	0.00981	CcSEcCtD
Ergotamine—Paraesthesia—Leflunomide—rheumatoid arthritis	0.000154	0.00967	CcSEcCtD
Ergotamine—Pain—Leflunomide—rheumatoid arthritis	0.000147	0.00921	CcSEcCtD
Ergotamine—Vertigo—Cyclosporine—rheumatoid arthritis	0.000146	0.00915	CcSEcCtD
Ergotamine—Bradycardia—Betamethasone—rheumatoid arthritis	0.000144	0.00905	CcSEcCtD
Ergotamine—Bradycardia—Dexamethasone—rheumatoid arthritis	0.000144	0.00905	CcSEcCtD
Ergotamine—Hypertension—Cyclosporine—rheumatoid arthritis	0.00014	0.00879	CcSEcCtD
Ergotamine—Myalgia—Cyclosporine—rheumatoid arthritis	0.000138	0.00867	CcSEcCtD
Ergotamine—Vertigo—Prednisolone—rheumatoid arthritis	0.000133	0.00833	CcSEcCtD
Ergotamine—Vertigo—Hydrocortisone—rheumatoid arthritis	0.00013	0.00813	CcSEcCtD
Ergotamine—Hypertension—Prednisolone—rheumatoid arthritis	0.000128	0.008	CcSEcCtD
Ergotamine—Bradycardia—Prednisone—rheumatoid arthritis	0.000126	0.00788	CcSEcCtD
Ergotamine—Hypertension—Hydrocortisone—rheumatoid arthritis	0.000125	0.00782	CcSEcCtD
Ergotamine—Asthenia—Leflunomide—rheumatoid arthritis	0.000123	0.00773	CcSEcCtD
Ergotamine—Myalgia—Hydrocortisone—rheumatoid arthritis	0.000123	0.00771	CcSEcCtD
Ergotamine—Vertigo—Triamcinolone—rheumatoid arthritis	0.000122	0.00766	CcSEcCtD
Ergotamine—Vertigo—Methylprednisolone—rheumatoid arthritis	0.000122	0.00764	CcSEcCtD
Ergotamine—Pruritus—Leflunomide—rheumatoid arthritis	0.000122	0.00762	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Cyclosporine—rheumatoid arthritis	0.000121	0.00757	CcSEcCtD
Ergotamine—Paraesthesia—Cyclosporine—rheumatoid arthritis	0.000119	0.00747	CcSEcCtD
Ergotamine—Tachycardia—Prednisolone—rheumatoid arthritis	0.000118	0.00738	CcSEcCtD
Ergotamine—Hypertension—Triamcinolone—rheumatoid arthritis	0.000117	0.00736	CcSEcCtD
Ergotamine—Hypertension—Methylprednisolone—rheumatoid arthritis	0.000117	0.00734	CcSEcCtD
Ergotamine—Myalgia—Triamcinolone—rheumatoid arthritis	0.000116	0.00726	CcSEcCtD
Ergotamine—Vomiting—Azathioprine—rheumatoid arthritis	0.000116	0.00725	CcSEcCtD
Ergotamine—Myalgia—Methylprednisolone—rheumatoid arthritis	0.000116	0.00724	CcSEcCtD
Ergotamine—Tachycardia—Hydrocortisone—rheumatoid arthritis	0.000115	0.00721	CcSEcCtD
Ergotamine—Pain—Cyclosporine—rheumatoid arthritis	0.000113	0.00711	CcSEcCtD
Ergotamine—Vertigo—Dexamethasone—rheumatoid arthritis	0.000111	0.00695	CcSEcCtD
Ergotamine—Vertigo—Betamethasone—rheumatoid arthritis	0.000111	0.00695	CcSEcCtD
Ergotamine—Vomiting—Leflunomide—rheumatoid arthritis	0.000109	0.00685	CcSEcCtD
Ergotamine—Paraesthesia—Prednisolone—rheumatoid arthritis	0.000108	0.00679	CcSEcCtD
Ergotamine—Tachycardia—Triamcinolone—rheumatoid arthritis	0.000108	0.00679	CcSEcCtD
Ergotamine—Nausea—Azathioprine—rheumatoid arthritis	0.000108	0.00678	CcSEcCtD
Ergotamine—Tachycardia—Methylprednisolone—rheumatoid arthritis	0.000108	0.00677	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Hydrocortisone—rheumatoid arthritis	0.000107	0.00673	CcSEcCtD
Ergotamine—Hypertension—Dexamethasone—rheumatoid arthritis	0.000107	0.00668	CcSEcCtD
Ergotamine—Hypertension—Betamethasone—rheumatoid arthritis	0.000107	0.00668	CcSEcCtD
Ergotamine—Paraesthesia—Hydrocortisone—rheumatoid arthritis	0.000106	0.00663	CcSEcCtD
Ergotamine—Myalgia—Betamethasone—rheumatoid arthritis	0.000105	0.00659	CcSEcCtD
Ergotamine—Myalgia—Dexamethasone—rheumatoid arthritis	0.000105	0.00659	CcSEcCtD
Ergotamine—Pain—Prednisolone—rheumatoid arthritis	0.000103	0.00647	CcSEcCtD
Ergotamine—Nausea—Leflunomide—rheumatoid arthritis	0.000102	0.0064	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	0.000101	0.00634	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	0.000101	0.00632	CcSEcCtD
Ergotamine—Pain—Hydrocortisone—rheumatoid arthritis	0.000101	0.00632	CcSEcCtD
Ergotamine—Paraesthesia—Triamcinolone—rheumatoid arthritis	9.97e-05	0.00625	CcSEcCtD
Ergotamine—Paraesthesia—Methylprednisolone—rheumatoid arthritis	9.94e-05	0.00623	CcSEcCtD
Ergotamine—Tachycardia—Betamethasone—rheumatoid arthritis	9.83e-05	0.00616	CcSEcCtD
Ergotamine—Tachycardia—Dexamethasone—rheumatoid arthritis	9.83e-05	0.00616	CcSEcCtD
Ergotamine—Vertigo—Prednisone—rheumatoid arthritis	9.65e-05	0.00605	CcSEcCtD
Ergotamine—Asthenia—Cyclosporine—rheumatoid arthritis	9.52e-05	0.00596	CcSEcCtD
Ergotamine—Pain—Triamcinolone—rheumatoid arthritis	9.49e-05	0.00595	CcSEcCtD
Ergotamine—Pruritus—Cyclosporine—rheumatoid arthritis	9.38e-05	0.00588	CcSEcCtD
Ergotamine—Hypertension—Prednisone—rheumatoid arthritis	9.28e-05	0.00582	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	9.17e-05	0.00575	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	9.17e-05	0.00575	CcSEcCtD
Ergotamine—Myalgia—Prednisone—rheumatoid arthritis	9.15e-05	0.00573	CcSEcCtD
Ergotamine—Paraesthesia—Dexamethasone—rheumatoid arthritis	9.04e-05	0.00567	CcSEcCtD
Ergotamine—Paraesthesia—Betamethasone—rheumatoid arthritis	9.04e-05	0.00567	CcSEcCtD
Ergotamine—Pain—Dexamethasone—rheumatoid arthritis	8.61e-05	0.0054	CcSEcCtD
Ergotamine—Pain—Betamethasone—rheumatoid arthritis	8.61e-05	0.0054	CcSEcCtD
Ergotamine—Tachycardia—Prednisone—rheumatoid arthritis	8.56e-05	0.00537	CcSEcCtD
Ergotamine—Asthenia—Hydrocortisone—rheumatoid arthritis	8.46e-05	0.0053	CcSEcCtD
Ergotamine—Vomiting—Cyclosporine—rheumatoid arthritis	8.43e-05	0.00529	CcSEcCtD
Ergotamine—Pruritus—Hydrocortisone—rheumatoid arthritis	8.34e-05	0.00523	CcSEcCtD
Ergotamine—Vertigo—Methotrexate—rheumatoid arthritis	8.07e-05	0.00506	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	7.99e-05	0.00501	CcSEcCtD
Ergotamine—Asthenia—Triamcinolone—rheumatoid arthritis	7.96e-05	0.00499	CcSEcCtD
Ergotamine—Asthenia—Methylprednisolone—rheumatoid arthritis	7.95e-05	0.00498	CcSEcCtD
Ergotamine—Nausea—Cyclosporine—rheumatoid arthritis	7.88e-05	0.00494	CcSEcCtD
Ergotamine—Paraesthesia—Prednisone—rheumatoid arthritis	7.87e-05	0.00494	CcSEcCtD
Ergotamine—Pruritus—Triamcinolone—rheumatoid arthritis	7.85e-05	0.00492	CcSEcCtD
Ergotamine—Pruritus—Methylprednisolone—rheumatoid arthritis	7.83e-05	0.00491	CcSEcCtD
Ergotamine—Myalgia—Methotrexate—rheumatoid arthritis	7.65e-05	0.00479	CcSEcCtD
Ergotamine—Vomiting—Hydrocortisone—rheumatoid arthritis	7.49e-05	0.0047	CcSEcCtD
Ergotamine—Asthenia—Betamethasone—rheumatoid arthritis	7.23e-05	0.00453	CcSEcCtD
Ergotamine—Asthenia—Dexamethasone—rheumatoid arthritis	7.23e-05	0.00453	CcSEcCtD
Ergotamine—Nausea—Prednisolone—rheumatoid arthritis	7.17e-05	0.00449	CcSEcCtD
Ergotamine—Pruritus—Dexamethasone—rheumatoid arthritis	7.12e-05	0.00447	CcSEcCtD
Ergotamine—Pruritus—Betamethasone—rheumatoid arthritis	7.12e-05	0.00447	CcSEcCtD
Ergotamine—Vomiting—Triamcinolone—rheumatoid arthritis	7.06e-05	0.00442	CcSEcCtD
Ergotamine—Vomiting—Methylprednisolone—rheumatoid arthritis	7.04e-05	0.00441	CcSEcCtD
Ergotamine—Nausea—Hydrocortisone—rheumatoid arthritis	7e-05	0.00439	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	6.68e-05	0.00419	CcSEcCtD
Ergotamine—Nausea—Triamcinolone—rheumatoid arthritis	6.59e-05	0.00413	CcSEcCtD
Ergotamine—Paraesthesia—Methotrexate—rheumatoid arthritis	6.58e-05	0.00413	CcSEcCtD
Ergotamine—Nausea—Methylprednisolone—rheumatoid arthritis	6.58e-05	0.00412	CcSEcCtD
Ergotamine—Vomiting—Dexamethasone—rheumatoid arthritis	6.4e-05	0.00401	CcSEcCtD
Ergotamine—Vomiting—Betamethasone—rheumatoid arthritis	6.4e-05	0.00401	CcSEcCtD
Ergotamine—Asthenia—Prednisone—rheumatoid arthritis	6.29e-05	0.00394	CcSEcCtD
Ergotamine—Pain—Methotrexate—rheumatoid arthritis	6.27e-05	0.00393	CcSEcCtD
Ergotamine—Pruritus—Prednisone—rheumatoid arthritis	6.2e-05	0.00389	CcSEcCtD
Ergotamine—Nausea—Betamethasone—rheumatoid arthritis	5.98e-05	0.00375	CcSEcCtD
Ergotamine—Nausea—Dexamethasone—rheumatoid arthritis	5.98e-05	0.00375	CcSEcCtD
Ergotamine—Vomiting—Prednisone—rheumatoid arthritis	5.58e-05	0.0035	CcSEcCtD
Ergotamine—Asthenia—Methotrexate—rheumatoid arthritis	5.26e-05	0.0033	CcSEcCtD
Ergotamine—Nausea—Prednisone—rheumatoid arthritis	5.21e-05	0.00327	CcSEcCtD
Ergotamine—Pruritus—Methotrexate—rheumatoid arthritis	5.19e-05	0.00325	CcSEcCtD
Ergotamine—Vomiting—Methotrexate—rheumatoid arthritis	4.66e-05	0.00292	CcSEcCtD
Ergotamine—Nausea—Methotrexate—rheumatoid arthritis	4.35e-05	0.00273	CcSEcCtD
Ergotamine—HTR2A—Signaling by GPCR—CXCL8—rheumatoid arthritis	5.89e-06	6.66e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—CCR5—rheumatoid arthritis	5.85e-06	6.61e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—CCL2—rheumatoid arthritis	5.84e-06	6.61e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—IL6R—rheumatoid arthritis	5.83e-06	6.59e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CCL5—rheumatoid arthritis	5.81e-06	6.57e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—SPP1—rheumatoid arthritis	5.79e-06	6.55e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—BGN—rheumatoid arthritis	5.78e-06	6.54e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—LEP—rheumatoid arthritis	5.77e-06	6.52e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—CXCL8—rheumatoid arthritis	5.77e-06	6.52e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—IL2RA—rheumatoid arthritis	5.76e-06	6.52e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—CCR5—rheumatoid arthritis	5.75e-06	6.5e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Hemostasis—TP53—rheumatoid arthritis	5.73e-06	6.48e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CSF2—rheumatoid arthritis	5.72e-06	6.47e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—IL2—rheumatoid arthritis	5.72e-06	6.47e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—C3—rheumatoid arthritis	5.71e-06	6.46e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—FN1—rheumatoid arthritis	5.71e-06	6.46e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—TYK2—rheumatoid arthritis	5.7e-06	6.45e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—IL6ST—rheumatoid arthritis	5.69e-06	6.43e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—FN1—rheumatoid arthritis	5.68e-06	6.43e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—CD80—rheumatoid arthritis	5.67e-06	6.42e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—IL2RA—rheumatoid arthritis	5.67e-06	6.41e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—IL6ST—rheumatoid arthritis	5.66e-06	6.4e-05	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—IL2—rheumatoid arthritis	5.64e-06	6.37e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—CCR5—rheumatoid arthritis	5.63e-06	6.37e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—IL2—rheumatoid arthritis	5.63e-06	6.36e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—C3—rheumatoid arthritis	5.62e-06	6.36e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—ENO1—rheumatoid arthritis	5.62e-06	6.35e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—NOS3—rheumatoid arthritis	5.6e-06	6.33e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—IL2RA—rheumatoid arthritis	5.55e-06	6.28e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	5.53e-06	6.25e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—IL2—rheumatoid arthritis	5.51e-06	6.23e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—C3—rheumatoid arthritis	5.5e-06	6.22e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—CD80—rheumatoid arthritis	5.48e-06	6.19e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—CD80—rheumatoid arthritis	5.45e-06	6.16e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—FN1—rheumatoid arthritis	5.44e-06	6.15e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—IL6ST—rheumatoid arthritis	5.42e-06	6.13e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—CXCL8—rheumatoid arthritis	5.4e-06	6.1e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—POMC—rheumatoid arthritis	5.39e-06	6.1e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—SPP1—rheumatoid arthritis	5.38e-06	6.08e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—CXCL8—rheumatoid arthritis	5.36e-06	6.06e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—ALOX5—rheumatoid arthritis	5.32e-06	6.02e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—LEP—rheumatoid arthritis	5.32e-06	6.01e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—TYK2—rheumatoid arthritis	5.31e-06	6e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—CXCL8—rheumatoid arthritis	5.29e-06	5.98e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—CCL2—rheumatoid arthritis	5.28e-06	5.96e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—IL6R—rheumatoid arthritis	5.26e-06	5.95e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CCR5—rheumatoid arthritis	5.23e-06	5.92e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—LEP—rheumatoid arthritis	5.23e-06	5.92e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—CD80—rheumatoid arthritis	5.22e-06	5.9e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—NOS3—rheumatoid arthritis	5.21e-06	5.89e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—POMC—rheumatoid arthritis	5.2e-06	5.88e-05	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—TP53—rheumatoid arthritis	5.18e-06	5.86e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—POMC—rheumatoid arthritis	5.18e-06	5.85e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—IL2RA—rheumatoid arthritis	5.16e-06	5.83e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—IL2—rheumatoid arthritis	5.16e-06	5.83e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling by GPCR—IL6—rheumatoid arthritis	5.13e-06	5.8e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—LEP—rheumatoid arthritis	5.12e-06	5.79e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—IL2—rheumatoid arthritis	5.12e-06	5.79e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—C3—rheumatoid arthritis	5.11e-06	5.78e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—CCL2—rheumatoid arthritis	5.09e-06	5.76e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—IL6R—rheumatoid arthritis	5.08e-06	5.74e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—CAT—rheumatoid arthritis	5.07e-06	5.73e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—CCL2—rheumatoid arthritis	5.07e-06	5.73e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—IL2—rheumatoid arthritis	5.05e-06	5.71e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—IL6R—rheumatoid arthritis	5.05e-06	5.71e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling by GPCR—IL6—rheumatoid arthritis	5.03e-06	5.68e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—FN1—rheumatoid arthritis	5.02e-06	5.67e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—IL6ST—rheumatoid arthritis	5e-06	5.65e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—CXCL8—rheumatoid arthritis	4.96e-06	5.61e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—POMC—rheumatoid arthritis	4.96e-06	5.6e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—FN1—rheumatoid arthritis	4.94e-06	5.58e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—IL6ST—rheumatoid arthritis	4.92e-06	5.56e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—POMC—rheumatoid arthritis	4.89e-06	5.53e-05	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—TP53—rheumatoid arthritis	4.89e-06	5.52e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—MMP9—rheumatoid arthritis	4.88e-06	5.52e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—CCL2—rheumatoid arthritis	4.85e-06	5.48e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	4.84e-06	5.47e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—IL6R—rheumatoid arthritis	4.83e-06	5.47e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—FN1—rheumatoid arthritis	4.83e-06	5.46e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—NFKB1—rheumatoid arthritis	4.83e-06	5.46e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—IL6ST—rheumatoid arthritis	4.81e-06	5.44e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—CD80—rheumatoid arthritis	4.81e-06	5.44e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—TYK2—rheumatoid arthritis	4.79e-06	5.42e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—MMP9—rheumatoid arthritis	4.78e-06	5.4e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—LEP—rheumatoid arthritis	4.76e-06	5.38e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—MAPK8—rheumatoid arthritis	4.75e-06	5.37e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—IL2—rheumatoid arthritis	4.74e-06	5.36e-05	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—IL6—rheumatoid arthritis	4.74e-06	5.36e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—CD80—rheumatoid arthritis	4.73e-06	5.35e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—NFKB1—rheumatoid arthritis	4.73e-06	5.35e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling by GPCR—IL6—rheumatoid arthritis	4.72e-06	5.34e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—NOS3—rheumatoid arthritis	4.7e-06	5.32e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—MAPK8—rheumatoid arthritis	4.65e-06	5.26e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—CD80—rheumatoid arthritis	4.63e-06	5.24e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—TYK2—rheumatoid arthritis	4.62e-06	5.23e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—CXCL8—rheumatoid arthritis	4.62e-06	5.22e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—TYK2—rheumatoid arthritis	4.6e-06	5.2e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—POMC—rheumatoid arthritis	4.57e-06	5.17e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—NOS3—rheumatoid arthritis	4.54e-06	5.13e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—NOS3—rheumatoid arthritis	4.52e-06	5.11e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—POMC—rheumatoid arthritis	4.5e-06	5.08e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—FN1—rheumatoid arthritis	4.49e-06	5.08e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—MMP9—rheumatoid arthritis	4.49e-06	5.08e-05	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—IL6—rheumatoid arthritis	4.47e-06	5.06e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—IL6ST—rheumatoid arthritis	4.47e-06	5.06e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—CCL2—rheumatoid arthritis	4.47e-06	5.06e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—ALB—rheumatoid arthritis	4.46e-06	5.04e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—IL6R—rheumatoid arthritis	4.46e-06	5.04e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—NFKB1—rheumatoid arthritis	4.44e-06	5.02e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—IL2—rheumatoid arthritis	4.41e-06	4.99e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—TYK2—rheumatoid arthritis	4.4e-06	4.98e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—POMC—rheumatoid arthritis	4.4e-06	4.98e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—CCL2—rheumatoid arthritis	4.4e-06	4.97e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—IL6—rheumatoid arthritis	4.39e-06	4.97e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—IL6R—rheumatoid arthritis	4.39e-06	4.96e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—VEGFA—rheumatoid arthritis	4.38e-06	4.96e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—MAPK8—rheumatoid arthritis	4.37e-06	4.94e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—ENO1—rheumatoid arthritis	4.34e-06	4.9e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—NOS3—rheumatoid arthritis	4.32e-06	4.89e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—CCL2—rheumatoid arthritis	4.31e-06	4.87e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CD80—rheumatoid arthritis	4.31e-06	4.87e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—IL6R—rheumatoid arthritis	4.29e-06	4.86e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—VEGFA—rheumatoid arthritis	4.29e-06	4.85e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—NOS3—rheumatoid arthritis	4.27e-06	4.82e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—MTHFR—rheumatoid arthritis	4.23e-06	4.78e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—MMP9—rheumatoid arthritis	4.18e-06	4.72e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—CXCL8—rheumatoid arthritis	4.17e-06	4.72e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—NFKB1—rheumatoid arthritis	4.13e-06	4.67e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—POMC—rheumatoid arthritis	4.09e-06	4.62e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—MAPK8—rheumatoid arthritis	4.06e-06	4.59e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—TYK2—rheumatoid arthritis	4.06e-06	4.59e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—CAT—rheumatoid arthritis	4.05e-06	4.57e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—VEGFA—rheumatoid arthritis	4.03e-06	4.56e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—CXCL8—rheumatoid arthritis	4.03e-06	4.55e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—TGFB1—rheumatoid arthritis	4.02e-06	4.55e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—CXCL8—rheumatoid arthritis	4.01e-06	4.53e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CCL2—rheumatoid arthritis	4e-06	4.53e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—TYK2—rheumatoid arthritis	3.99e-06	4.52e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—IL6R—rheumatoid arthritis	3.99e-06	4.51e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—IL2—rheumatoid arthritis	3.99e-06	4.51e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—NOS3—rheumatoid arthritis	3.99e-06	4.51e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—IL6—rheumatoid arthritis	3.97e-06	4.48e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—TGFB1—rheumatoid arthritis	3.94e-06	4.45e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—NOS3—rheumatoid arthritis	3.92e-06	4.43e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—TYK2—rheumatoid arthritis	3.91e-06	4.42e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Metabolism—PTGS2—rheumatoid arthritis	3.9e-06	4.41e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—IL2—rheumatoid arthritis	3.85e-06	4.35e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—NOS3—rheumatoid arthritis	3.84e-06	4.34e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—CXCL8—rheumatoid arthritis	3.83e-06	4.33e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—IL6—rheumatoid arthritis	3.83e-06	4.33e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—IL2—rheumatoid arthritis	3.83e-06	4.33e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—IL6—rheumatoid arthritis	3.81e-06	4.31e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—MMP9—rheumatoid arthritis	3.77e-06	4.27e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—VEGFA—rheumatoid arthritis	3.75e-06	4.24e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—NFKB1—rheumatoid arthritis	3.73e-06	4.22e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—TGFB1—rheumatoid arthritis	3.7e-06	4.18e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—MAPK8—rheumatoid arthritis	3.67e-06	4.15e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—IL2—rheumatoid arthritis	3.66e-06	4.14e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—IL6—rheumatoid arthritis	3.65e-06	4.12e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—MMP9—rheumatoid arthritis	3.64e-06	4.12e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—TYK2—rheumatoid arthritis	3.63e-06	4.11e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—MMP9—rheumatoid arthritis	3.62e-06	4.1e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—NFKB1—rheumatoid arthritis	3.6e-06	4.07e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—NFKB1—rheumatoid arthritis	3.58e-06	4.05e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—NOS3—rheumatoid arthritis	3.57e-06	4.03e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—MAPK8—rheumatoid arthritis	3.54e-06	4e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—CXCL8—rheumatoid arthritis	3.53e-06	4e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—MAPK8—rheumatoid arthritis	3.52e-06	3.98e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—CXCL8—rheumatoid arthritis	3.48e-06	3.93e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—MMP9—rheumatoid arthritis	3.47e-06	3.92e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—TGFB1—rheumatoid arthritis	3.44e-06	3.89e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—NFKB1—rheumatoid arthritis	3.43e-06	3.88e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—CXCL8—rheumatoid arthritis	3.41e-06	3.85e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—VEGFA—rheumatoid arthritis	3.39e-06	3.83e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—POMC—rheumatoid arthritis	3.38e-06	3.82e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—IL2—rheumatoid arthritis	3.38e-06	3.82e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—MTHFR—rheumatoid arthritis	3.38e-06	3.82e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—MAPK8—rheumatoid arthritis	3.37e-06	3.81e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—IL6—rheumatoid arthritis	3.36e-06	3.8e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—IL2—rheumatoid arthritis	3.32e-06	3.76e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—TP53—rheumatoid arthritis	3.31e-06	3.75e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—IL6—rheumatoid arthritis	3.31e-06	3.74e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—VEGFA—rheumatoid arthritis	3.27e-06	3.7e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—IL2—rheumatoid arthritis	3.25e-06	3.68e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—VEGFA—rheumatoid arthritis	3.25e-06	3.68e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—TP53—rheumatoid arthritis	3.24e-06	3.67e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—IL6—rheumatoid arthritis	3.24e-06	3.66e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—MMP9—rheumatoid arthritis	3.2e-06	3.61e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CXCL8—rheumatoid arthritis	3.16e-06	3.58e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—NFKB1—rheumatoid arthritis	3.16e-06	3.58e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—MMP9—rheumatoid arthritis	3.15e-06	3.56e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—CAT—rheumatoid arthritis	3.12e-06	3.53e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—VEGFA—rheumatoid arthritis	3.11e-06	3.52e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—NFKB1—rheumatoid arthritis	3.11e-06	3.52e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—MAPK8—rheumatoid arthritis	3.11e-06	3.52e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—TGFB1—rheumatoid arthritis	3.11e-06	3.52e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—ALB—rheumatoid arthritis	3.08e-06	3.49e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—MMP9—rheumatoid arthritis	3.08e-06	3.48e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—MAPK8—rheumatoid arthritis	3.06e-06	3.46e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—NFKB1—rheumatoid arthritis	3.05e-06	3.45e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—TP53—rheumatoid arthritis	3.05e-06	3.44e-05	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—IL6—rheumatoid arthritis	3.03e-06	3.43e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—IL2—rheumatoid arthritis	3.02e-06	3.42e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—IL6—rheumatoid arthritis	3.01e-06	3.4e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—TGFB1—rheumatoid arthritis	3e-06	3.39e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—MAPK8—rheumatoid arthritis	3e-06	3.39e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—TGFB1—rheumatoid arthritis	2.99e-06	3.38e-05	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—IL6—rheumatoid arthritis	2.97e-06	3.36e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—NOS3—rheumatoid arthritis	2.95e-06	3.34e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—VEGFA—rheumatoid arthritis	2.87e-06	3.25e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—MMP9—rheumatoid arthritis	2.86e-06	3.24e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—TGFB1—rheumatoid arthritis	2.86e-06	3.23e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—TP53—rheumatoid arthritis	2.83e-06	3.21e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—NFKB1—rheumatoid arthritis	2.83e-06	3.2e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—VEGFA—rheumatoid arthritis	2.82e-06	3.19e-05	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—IL6—rheumatoid arthritis	2.79e-06	3.15e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—MAPK8—rheumatoid arthritis	2.78e-06	3.15e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—VEGFA—rheumatoid arthritis	2.77e-06	3.13e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—POMC—rheumatoid arthritis	2.7e-06	3.05e-05	CbGpPWpGaD
Ergotamine—ABCB1—Metabolism—PTGS2—rheumatoid arthritis	2.7e-06	3.05e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—TGFB1—rheumatoid arthritis	2.64e-06	2.98e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—MTHFR—rheumatoid arthritis	2.61e-06	2.95e-05	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—IL6—rheumatoid arthritis	2.59e-06	2.93e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—TGFB1—rheumatoid arthritis	2.59e-06	2.93e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—VEGFA—rheumatoid arthritis	2.57e-06	2.91e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—TP53—rheumatoid arthritis	2.56e-06	2.89e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—TGFB1—rheumatoid arthritis	2.54e-06	2.87e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—TP53—rheumatoid arthritis	2.47e-06	2.79e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—ALB—rheumatoid arthritis	2.46e-06	2.78e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—TP53—rheumatoid arthritis	2.46e-06	2.78e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—TGFB1—rheumatoid arthritis	2.36e-06	2.67e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—NOS3—rheumatoid arthritis	2.36e-06	2.66e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—TP53—rheumatoid arthritis	2.35e-06	2.66e-05	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—IL6—rheumatoid arthritis	2.34e-06	2.65e-05	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—IL6—rheumatoid arthritis	2.26e-06	2.56e-05	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—IL6—rheumatoid arthritis	2.25e-06	2.54e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—TP53—rheumatoid arthritis	2.17e-06	2.45e-05	CbGpPWpGaD
Ergotamine—CYP1A2—Metabolism—PTGS2—rheumatoid arthritis	2.15e-06	2.44e-05	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—IL6—rheumatoid arthritis	2.15e-06	2.44e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—TP53—rheumatoid arthritis	2.13e-06	2.41e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—TP53—rheumatoid arthritis	2.09e-06	2.36e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—POMC—rheumatoid arthritis	2.08e-06	2.36e-05	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—IL6—rheumatoid arthritis	1.99e-06	2.25e-05	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—IL6—rheumatoid arthritis	1.95e-06	2.21e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—TP53—rheumatoid arthritis	1.94e-06	2.2e-05	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—IL6—rheumatoid arthritis	1.91e-06	2.16e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—ALB—rheumatoid arthritis	1.9e-06	2.15e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—NOS3—rheumatoid arthritis	1.82e-06	2.05e-05	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—IL6—rheumatoid arthritis	1.78e-06	2.01e-05	CbGpPWpGaD
Ergotamine—CYP3A4—Metabolism—PTGS2—rheumatoid arthritis	1.66e-06	1.88e-05	CbGpPWpGaD
